HSBC Holdings’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$547K Buy
278,930
+89,271
+47% +$175K ﹤0.01% 1668
2025
Q1
$326K Buy
189,659
+46,436
+32% +$79.9K ﹤0.01% 1890
2024
Q4
$378K Buy
143,223
+25,870
+22% +$68.3K ﹤0.01% 1945
2024
Q3
$277K Sell
117,353
-15,955
-12% -$37.6K ﹤0.01% 2043
2024
Q2
$425K Sell
133,308
-58,233
-30% -$186K ﹤0.01% 1724
2024
Q1
$697K Buy
191,541
+16,597
+9% +$60.4K ﹤0.01% 1570
2023
Q4
$262K Buy
174,944
+117
+0.1% +$176 ﹤0.01% 1892
2023
Q3
$238K Buy
174,827
+62,844
+56% +$85.5K ﹤0.01% 1845
2023
Q2
$200K Buy
111,983
+12,540
+13% +$22.4K ﹤0.01% 1901
2023
Q1
$165K Buy
99,443
+17,413
+21% +$28.9K ﹤0.01% 2002
2022
Q4
$154K Buy
82,030
+53,941
+192% +$101K ﹤0.01% 2354
2022
Q3
$66K Buy
+28,089
New +$66K ﹤0.01% 2346
2021
Q3
Sell
-10,587
Closed -$98K 2606
2021
Q2
$98K Buy
+10,587
New +$98K ﹤0.01% 2407